To access this element change to forms mode OFF
Grant Award View - GA271252
“Off-the-shelf†CAR-T cell immunotherapy for brain cancer
GA ID:
GA271252
Agency:
Department of Health and Aged Care
Approval Date:
23-Sep-2022
Publish Date:
31-Oct-2022
Category:
Medical Research
Grant Term:
1-Nov-2022 to 31-Oct-2024
Value (AUD):
$329,489.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
“Off-the-shelf†CAR-T cell immunotherapy for brain cancer
Purpose:
Over the last two decades the overall survival of brain cancer patients have remained largely unchanged. Our group has previously shown that adoptive T cell therapy directed to a common herpesvirus, CMV can be safely used for the treatment of brain cancer patients and this therapy can offer clinical benefit to some patients. In this project we are aiming to assess a novel dual targeting T cell therapy which is specifically designed to target tumour-nourishing cancer stem cells.
GO ID:
GO Title:
MRFF – Australian Brain Cancer Mission – 2021 Brain Cancer Research Grant Opportunity
Internal Reference ID:
2022/MRF2021878
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Council of the Queensland Institute of Medical Research
Recipient ABN:
31 411 813 344
Grant Recipient Location
Suburb:
Herston
Town/City:
Herston
Postcode:
4006
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
Country:
AUSTRALIA